Company Filing History:
4 out of 1,647 
3 out of 116 
2 out of 28 
Years Active: 1998-2000
Title: David E. Goldgar: A Pioneer in Genetic Research
Introduction
David E. Goldgar is a notable inventor and genetic researcher based in Salt Lake City, Utah. With a total of four patents to his name, Goldgar has made significant contributions to the understanding of breast and ovarian cancer susceptibility genes. His work has enhanced diagnostic and therapeutic approaches in the field of genetics.
Latest Patents
Goldgar's latest patents primarily focus on the BRCA1 gene, which is critical in assessing predisposing factors for breast and ovarian cancer. His inventions include methods and materials aimed at isolating and detecting the BRCA1 gene, identifying germline mutations, and utilizing these mutations for diagnostic purposes. Goldgar's patents also address the implications of somatic mutations in various human cancers, offering insights into diagnosis, prognosis, and therapy options including gene therapy and drug screening.
Career Highlights
Throughout his career, David E. Goldgar has held significant positions at esteemed institutions, including the University of Utah Research Foundation and Myriad Genetics, Inc. His work has positioned him at the forefront of genetic research and innovation, particularly regarding cancer susceptibility.
Collaborations
Goldgar has collaborated with prominent colleagues in the field, including Mark H. Skolnick and Yoshio Miki. These partnerships have facilitated groundbreaking research and have contributed to advancements in cancer genetic studies.
Conclusion
David E. Goldgar's innovations have not only expanded scientific knowledge surrounding breast and ovarian cancer but also improved methods for diagnosing and treating these serious conditions. His ongoing contributions to the field of genetics continue to have a lasting impact on cancer research and patient care.